Global Dapoxetine 麻豆原创 Research Report 2024

Publication ID:

PB501243111

Publication Date:

January 29, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Dapoxetine, marketed as Priligy, is a medication used for the treatment of premature ejaculation (PE) in men 18鈥�64 years old.听Dapoxetine听works by inhibiting the serotonin transporter, increasing serotonin's action at the post synaptic cleft, and as a consequence promoting ejaculatory delay.
The global Dapoxetine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dapoxetine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dapoxetine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dapoxetine include Johnson & Johnson, Menarini, Hetero Healthcare, Sun Pharmaceuticals, Emcure Pharmaceuticals, Kelun Pharmaceutical, HUaPont Pharma, Hicin Pharmaceutical and Huiyinbi Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dapoxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dapoxetine.
Report Scope
The Dapoxetine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dapoxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dapoxetine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Johnson & Johnson
Menarini
Hetero Healthcare
Sun Pharmaceuticals
Emcure Pharmaceuticals
Kelun Pharmaceutical
HUaPont Pharma
Hicin Pharmaceutical
Huiyinbi Group
Sino Pharma
Kinhoo Pharmaceutical
Salubris
Lancom
Lianhuan Group
Northeast Pharmaceutical
Guangzhou Baiyunshan Pharma
Segment by Type
30 mg
60 mg
Segment by Application
Offline Channel
Online Channel
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dapoxetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dapoxetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Dapoxetine 麻豆原创 Overview
1.1 Product Overview and Scope of Dapoxetine
1.2 Dapoxetine Segment by Type
1.2.1 Global Dapoxetine 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 30 mg
1.2.3 60 mg
1.3 Dapoxetine Segment by Application
1.3.1 Global Dapoxetine 麻豆原创 Value by Application: (2024-2030)
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Global Dapoxetine 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Dapoxetine Revenue 2019-2030
1.4.2 Global Dapoxetine Sales 2019-2030
1.4.3 Global Dapoxetine 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dapoxetine 麻豆原创 Competition by Manufacturers
2.1 Global Dapoxetine Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Dapoxetine Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Dapoxetine Average Price by Manufacturers (2019-2024)
2.4 Global Dapoxetine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dapoxetine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dapoxetine, Product Type & Application
2.7 Dapoxetine 麻豆原创 Competitive Situation and Trends
2.7.1 Dapoxetine 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dapoxetine Players 麻豆原创 Share by Revenue
2.7.3 Global Dapoxetine 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dapoxetine Retrospective 麻豆原创 Scenario by Region
3.1 Global Dapoxetine 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dapoxetine Global Dapoxetine Sales by Region: 2019-2030
3.2.1 Global Dapoxetine Sales by Region: 2019-2024
3.2.2 Global Dapoxetine Sales by Region: 2025-2030
3.3 Global Dapoxetine Global Dapoxetine Revenue by Region: 2019-2030
3.3.1 Global Dapoxetine Revenue by Region: 2019-2024
3.3.2 Global Dapoxetine Revenue by Region: 2025-2030
3.4 North America Dapoxetine 麻豆原创 Facts & Figures by Country
3.4.1 North America Dapoxetine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dapoxetine Sales by Country (2019-2030)
3.4.3 North America Dapoxetine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dapoxetine 麻豆原创 Facts & Figures by Country
3.5.1 Europe Dapoxetine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dapoxetine Sales by Country (2019-2030)
3.5.3 Europe Dapoxetine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dapoxetine 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Dapoxetine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dapoxetine Sales by Country (2019-2030)
3.6.3 Asia Pacific Dapoxetine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dapoxetine 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Dapoxetine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dapoxetine Sales by Country (2019-2030)
3.7.3 Latin America Dapoxetine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dapoxetine 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Dapoxetine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dapoxetine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dapoxetine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dapoxetine Sales by Type (2019-2030)
4.1.1 Global Dapoxetine Sales by Type (2019-2024)
4.1.2 Global Dapoxetine Sales by Type (2025-2030)
4.1.3 Global Dapoxetine Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Dapoxetine Revenue by Type (2019-2030)
4.2.1 Global Dapoxetine Revenue by Type (2019-2024)
4.2.2 Global Dapoxetine Revenue by Type (2025-2030)
4.2.3 Global Dapoxetine Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Dapoxetine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dapoxetine Sales by Application (2019-2030)
5.1.1 Global Dapoxetine Sales by Application (2019-2024)
5.1.2 Global Dapoxetine Sales by Application (2025-2030)
5.1.3 Global Dapoxetine Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Dapoxetine Revenue by Application (2019-2030)
5.2.1 Global Dapoxetine Revenue by Application (2019-2024)
5.2.2 Global Dapoxetine Revenue by Application (2025-2030)
5.2.3 Global Dapoxetine Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Dapoxetine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Dapoxetine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Menarini
6.2.1 Menarini Corporation Information
6.2.2 Menarini Description and Business Overview
6.2.3 Menarini Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Menarini Dapoxetine Product Portfolio
6.2.5 Menarini Recent Developments/Updates
6.3 Hetero Healthcare
6.3.1 Hetero Healthcare Corporation Information
6.3.2 Hetero Healthcare Description and Business Overview
6.3.3 Hetero Healthcare Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hetero Healthcare Dapoxetine Product Portfolio
6.3.5 Hetero Healthcare Recent Developments/Updates
6.4 Sun Pharmaceuticals
6.4.1 Sun Pharmaceuticals Corporation Information
6.4.2 Sun Pharmaceuticals Description and Business Overview
6.4.3 Sun Pharmaceuticals Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceuticals Dapoxetine Product Portfolio
6.4.5 Sun Pharmaceuticals Recent Developments/Updates
6.5 Emcure Pharmaceuticals
6.5.1 Emcure Pharmaceuticals Corporation Information
6.5.2 Emcure Pharmaceuticals Description and Business Overview
6.5.3 Emcure Pharmaceuticals Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Emcure Pharmaceuticals Dapoxetine Product Portfolio
6.5.5 Emcure Pharmaceuticals Recent Developments/Updates
6.6 Kelun Pharmaceutical
6.6.1 Kelun Pharmaceutical Corporation Information
6.6.2 Kelun Pharmaceutical Description and Business Overview
6.6.3 Kelun Pharmaceutical Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kelun Pharmaceutical Dapoxetine Product Portfolio
6.6.5 Kelun Pharmaceutical Recent Developments/Updates
6.7 HUaPont Pharma
6.6.1 HUaPont Pharma Corporation Information
6.6.2 HUaPont Pharma Description and Business Overview
6.6.3 HUaPont Pharma Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HUaPont Pharma Dapoxetine Product Portfolio
6.7.5 HUaPont Pharma Recent Developments/Updates
6.8 Hicin Pharmaceutical
6.8.1 Hicin Pharmaceutical Corporation Information
6.8.2 Hicin Pharmaceutical Description and Business Overview
6.8.3 Hicin Pharmaceutical Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hicin Pharmaceutical Dapoxetine Product Portfolio
6.8.5 Hicin Pharmaceutical Recent Developments/Updates
6.9 Huiyinbi Group
6.9.1 Huiyinbi Group Corporation Information
6.9.2 Huiyinbi Group Description and Business Overview
6.9.3 Huiyinbi Group Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Huiyinbi Group Dapoxetine Product Portfolio
6.9.5 Huiyinbi Group Recent Developments/Updates
6.10 Sino Pharma
6.10.1 Sino Pharma Corporation Information
6.10.2 Sino Pharma Description and Business Overview
6.10.3 Sino Pharma Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sino Pharma Dapoxetine Product Portfolio
6.10.5 Sino Pharma Recent Developments/Updates
6.11 Kinhoo Pharmaceutical
6.11.1 Kinhoo Pharmaceutical Corporation Information
6.11.2 Kinhoo Pharmaceutical Dapoxetine Description and Business Overview
6.11.3 Kinhoo Pharmaceutical Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kinhoo Pharmaceutical Dapoxetine Product Portfolio
6.11.5 Kinhoo Pharmaceutical Recent Developments/Updates
6.12 Salubris
6.12.1 Salubris Corporation Information
6.12.2 Salubris Dapoxetine Description and Business Overview
6.12.3 Salubris Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Salubris Dapoxetine Product Portfolio
6.12.5 Salubris Recent Developments/Updates
6.13 Lancom
6.13.1 Lancom Corporation Information
6.13.2 Lancom Dapoxetine Description and Business Overview
6.13.3 Lancom Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lancom Dapoxetine Product Portfolio
6.13.5 Lancom Recent Developments/Updates
6.14 Lianhuan Group
6.14.1 Lianhuan Group Corporation Information
6.14.2 Lianhuan Group Dapoxetine Description and Business Overview
6.14.3 Lianhuan Group Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lianhuan Group Dapoxetine Product Portfolio
6.14.5 Lianhuan Group Recent Developments/Updates
6.15 Northeast Pharmaceutical
6.15.1 Northeast Pharmaceutical Corporation Information
6.15.2 Northeast Pharmaceutical Dapoxetine Description and Business Overview
6.15.3 Northeast Pharmaceutical Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Northeast Pharmaceutical Dapoxetine Product Portfolio
6.15.5 Northeast Pharmaceutical Recent Developments/Updates
6.16 Guangzhou Baiyunshan Pharma
6.16.1 Guangzhou Baiyunshan Pharma Corporation Information
6.16.2 Guangzhou Baiyunshan Pharma Dapoxetine Description and Business Overview
6.16.3 Guangzhou Baiyunshan Pharma Dapoxetine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Guangzhou Baiyunshan Pharma Dapoxetine Product Portfolio
6.16.5 Guangzhou Baiyunshan Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dapoxetine Industry Chain Analysis
7.2 Dapoxetine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dapoxetine Production Mode & Process
7.4 Dapoxetine Sales and 麻豆原创ing
7.4.1 Dapoxetine Sales Channels
7.4.2 Dapoxetine Distributors
7.5 Dapoxetine Customers
8 Dapoxetine 麻豆原创 Dynamics
8.1 Dapoxetine Industry Trends
8.2 Dapoxetine 麻豆原创 Drivers
8.3 Dapoxetine 麻豆原创 Challenges
8.4 Dapoxetine 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Johnson & Johnson
Menarini
Hetero Healthcare
Sun Pharmaceuticals
Emcure Pharmaceuticals
Kelun Pharmaceutical
HUaPont Pharma
Hicin Pharmaceutical
Huiyinbi Group
Sino Pharma
Kinhoo Pharmaceutical
Salubris
Lancom
Lianhuan Group
Northeast Pharmaceutical
Guangzhou Baiyunshan Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.